Oncocyte Corp Quarterly Common Stock, Shares Authorized from Q4 2015 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Oncocyte Corp quarterly Common Stock, Shares Authorized history and growth rate from Q4 2015 to Q2 2024.
  • Oncocyte Corp Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 230M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 230M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 230M 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 230M 0 0% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 230M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 230M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 230M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 230M 0 0% Dec 31, 2022 10-K 2024-04-16
Q3 2022 230M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 230M 0 0% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 230M +80M +53.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 230M 0 0% Dec 31, 2021 10-K 2023-04-12
Q3 2021 230M +80M +53.3% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 230M +80M +53.3% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 150M +65M +76.5% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 230M +80M +53.3% Dec 31, 2020 10-K 2022-03-11
Q3 2020 150M +65M +76.5% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 150M +65M +76.5% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 85M 0 0% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 150M +65M +76.5% Dec 31, 2019 10-K 2021-03-19
Q3 2019 85M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 85M +35M +70% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 85M +35M +70% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 85M 0 0% Dec 31, 2018 10-K 2020-03-26
Q3 2018 85M +35M +70% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 50M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 50M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 85M +35M +70% Dec 31, 2017 10-K 2019-04-01
Q3 2017 50M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 50M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 50M 0 0% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 50M 0 0% Dec 31, 2016 10-K 2018-04-02
Q3 2016 50M Sep 30, 2016 10-Q 2016-11-10
Q2 2016 50M Jun 30, 2016 10-Q 2016-08-11
Q1 2016 50M Mar 31, 2016 10-Q 2016-05-16
Q4 2015 50M Dec 31, 2015 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.